The number of recombinant proteins used for academic research and therapeutic applications has increased dramatically.
However, successful recombinant protein expression depends on so many factors such as codon preference, RNA secondary
structure, GC content in heterologous expression systems. More and more experimental results proved that the expression
level was dramatically increased, from two to one hundred times depending on different genes, when compared with pre-
optimization. Bioclone has developed a unique cDNA (cloned in E.coli expression Vector, Fig.1) and recombinant protein
(Produced in E.coli or Sf9 insect cell). Bioclone provides ready-to-use and customer-based service for all the cDNA clones
and recombinant proteins.
Those cDNA clones and recombinant proteins include:
Infection disease antigens (Virus, Bacterial, Parasites), Nuclear Protein, Cytokines, Kinase, G-protein, Receptor,
Phosphatase, Protease, Signal Transduction, Apoptosis, Stem Cell and Development, Extracellular Matrix,
Neuroscience, Toxicology, Drug metabollism, Common Disease, Transcription factors and Cancer.
|
